Skip to main content

Find Clinical Trials

Home
Conditions
Rotavirus Infections

Clinical trial condition

Rotavirus Infections

Explore clinical trials studying Rotavirus Infections. Study availability and eligibility vary by location and protocol.

90 public trials 1 recruiting study

Refine in advanced search Browse all conditions

Rotavirus Infections trial results

Completed

Year 3 Extension for Efficacy Follow-up in Subjects Vaccinated in Studies Rota-028, 029 or 030 (NCT00197210)

NCT00329745

Conditions: Infections, Infections, Rotavirus, RNA Virus Infections, +3 more
Locations: GSK Investigational Site Singapore

GSK Investigational Site Singapore

GSK Investigational Site Singapore

GSK Investigational Site Singapore

View Trial Details

Completed

A Study in Infants to Test Two Preparations (Freeze-dried or Liquid) of the Rotavirus Vaccine (HRV Vaccine).

NCT00382772

Conditions: Diarrhea, Infections, Infections, Rotavirus, +7 more
Locations: GSK Investigational Site Espoo, Finland

GSK Investigational Site Helsinki, Finland

GSK Investigational Site Helsinki, Finland

GSK Investigational Site Jarvenpaa, Finland

View Trial Details

Completed

A Study to Test 2 Doses of GSK Biologicals' Oral Live Attenuated Human Rotavirus (HRV) Vaccine in Healthy Infants

NCT00197210

Conditions: Infections, Infections, Rotavirus, RNA Virus Infections, +3 more
Locations: GSK Investigational Site Singapore

GSK Investigational Site Singapore

GSK Investigational Site Singapore

GSK Investigational Site Singapore

View Trial Details

Completed

Study of 2 Doses of HRV Vaccine Given Concomitantly or Separately With Routine Vaccinations in Healthy Infants in USA

NCT00334607

Conditions: Diarrhea, Infections, Infections, Rotavirus, +7 more
Locations: GSK Investigational Site Benton, Arkansas, United States

GSK Investigational Site Cabot, Arkansas, United States

GSK Investigational Site Jonesboro, Arkansas, United States

GSK Investigational Site Little Rock, Arkansas, United States

View all 42 locations

View Trial Details

Completed

Study of 2 Doses of HRV Vaccine Given Concomitantly With Routine EPI Vaccinations Including OPV in Healthy Infants

NCT00139347

Conditions: Infections, Infections, Rotavirus, RNA Virus Infections, +3 more
Locations: GSK Investigational Site Colonia Caroya, Córdoba Province, Argentina

GSK Investigational Site Córdoba, Córdoba Province, Argentina

GSK Investigational Site Río Cuarto, Córdoba Province, Argentina

GSK Investigational Site Mendoza, Mendoza Province, Argentina

View all 17 locations

View Trial Details

Completed

To Evaluate Immunogenicity, Reactogenicity & Safety of 2 Doses of GSK Bio HRV Liquid Vaccine Given to Infants (Vietnam)

NCT00345956

Conditions: Infections, Infections, Rotavirus, RNA Virus Infections, +3 more
Locations: GSK Investigational Site Hanoi, Vietnam

GSK Investigational Site Nhatrang, Vietnam

View Trial Details

Completed

Study of 2 Doses of Oral Live Attenuated Human Rotavirus (HRV) Vaccine for the Prophylaxis of Rotavirus Gastroenteritis

NCT00134732

Conditions: Infections, Infections, Rotavirus, RNA Virus Infections, +3 more
Locations: GSK Investigational Site Bucheon-si, South Korea

GSK Investigational Site Daejeon, South Korea

GSK Investigational Site Jeonju, South Korea

GSK Investigational Site Seoul, South Korea

View Trial Details

Completed

A Study to Test 2 Doses of the HRV Vaccine Given With or Without OPV in Healthy Infants in Bangladesh

NCT00139334

Conditions: Infections, Infections, Rotavirus, RNA Virus Infections, +3 more
Locations: GSK Investigational Site Dhaka, Bangladesh

View Trial Details

Completed

Study of Immunogenicity & Safety of 2 Different Formulations of Human Rotavirus (HRV) Vaccine for the Prophylaxis of Rotavirus Gastroenteritis

NCT00137930

Conditions: Infections, Infections, Rotavirus, RNA Virus Infections, +3 more
Locations: GSK Investigational Site Lahti, Finland

GSK Investigational Site Oulu, Finland

GSK Investigational Site Pori, Finland

GSK Investigational Site Tampere, Finland

View Trial Details

Completed

Study of Two Doses of GSK Biologicals' Live Attenuated HRV Vaccine (Two Different Formulations) in Healthy Infants.

NCT00729001

Conditions: Infections, Infections, Rotavirus, RNA Virus Infections, +3 more
Locations: Not specified

View Trial Details